Ameriprise
SCPH

Ameriprise’s scPharmaceuticals SCPH Stock Holding History

Ameriprise’s Portfolio SCPH Stock Details SCPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-85,863
Closed -$431K – 3929
2024
Q1 		$431K Sell
85,863
-2,009
-2% -$11.3K ﹤0.01% 3464
2023
Q4 		$551K Sell
87,872
-12,727
-13% -$72.9K ﹤0.01% 3423
2023
Q3 		$716K Sell
100,599
-894
-0.9% -$7.04K ﹤0.01% 3280
2023
Q2 		$1.03M Buy
101,493
+4,896
+5% +$51.1K ﹤0.01% 3158
2023
Q1 		$876K Buy
+96,597
New +$708K ﹤0.01% 3217

Other funds holding SCPH

O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
Luther King Capital Management (LKCM)
Luther King Capital Management (LKCM) Fort Worth, Texas $24.4B AUM 22.19% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $288M AUM 313.93% 1-Year Est. Return
Thrivent Financial for Lutherans
Thrivent Financial for Lutherans Minneapolis, Minnesota $59.5B AUM 35.96% 1-Year Est. Return
JGC
J. Goldman & Co New York $3.87B AUM 46.92% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Ameriprise's SCPH Position: Q2 2024 in Review

Ameriprise sold out of scPharmaceuticals (SCPH) in Q2 2024, closing a stake of 85,863 shares — an estimated $431K sold.

Ameriprise first reported a position in SCPH in Q1 2023 and held it in 5 quarters. The position peaked at $1.03M in Q2 2023. 77 funds tracked by Wall St. Rank hold SCPH as of Q2 2024.

  • Ameriprise reported no remaining scPharmaceuticals position as of Q2 2024 after selling out during the quarter.
  • Ameriprise sold 85,863 scPharmaceuticals shares in Q2 2024, an estimated $431K.
  • Ameriprise first reported a position in scPharmaceuticals in Q1 2023 and held it in 5 quarters.
  • Ameriprise's scPharmaceuticals position peaked at $1.03M in Q2 2023.
  • 77 funds tracked by Wall St. Rank held scPharmaceuticals as of Q2 2024.

Based on Ameriprise's 13F filing for Q2 2024, filed 14 Aug 2024.